These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37482682)

  • 1. PARP1 modulates METTL3 promoter chromatin accessibility and associated LPAR5 RNA m
    Sun X; Bai C; Li H; Xie D; Chen S; Han Y; Luo J; Li Y; Ye Y; Jia J; Huang X; Guan H; Long D; Huang R; Gao S; Zhou PK
    Mol Ther; 2023 Sep; 31(9):2633-2650. PubMed ID: 37482682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. METTL3 promotes oxaliplatin resistance of gastric cancer CD133+ stem cells by promoting PARP1 mRNA stability.
    Li H; Wang C; Lan L; Yan L; Li W; Evans I; Ruiz EJ; Su Q; Zhao G; Wu W; Zhang H; Zhou Z; Hu Z; Chen W; Oliveira JM; Behrens A; Reis RL; Zhang C
    Cell Mol Life Sci; 2022 Feb; 79(3):135. PubMed ID: 35179655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic control of chromatin-associated m
    Xu W; He C; Kaye EG; Li J; Mu M; Nelson GM; Dong L; Wang J; Wu F; Shi YG; Adelman K; Lan F; Shi Y; Shen H
    Mol Cell; 2022 Mar; 82(6):1156-1168.e7. PubMed ID: 35219383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. m
    Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
    J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mettl3-mediated m
    Jiang FQ; Liu K; Chen JX; Cao Y; Chen WY; Zhao WL; Song GH; Liang CQ; Zhou YM; Huang HL; Huang RJ; Zhao H; Park KS; Ju Z; Cai D; Qi XF
    Elife; 2022 Nov; 11():. PubMed ID: 36399125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PARP1 interacts with WDR5 to enhance target gene recognition and facilitate tumorigenesis.
    Qin Y; Dong X; Lu M; Jing L; Chen Q; Guan F; Xiang Z; Huang J; Yang C; He X; Qu J; Yang Z
    Cancer Lett; 2024 Jul; 593():216952. PubMed ID: 38750719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 Promotes Tumorigenesis and Metastasis through BMI1 m
    Liu L; Wu Y; Li Q; Liang J; He Q; Zhao L; Chen J; Cheng M; Huang Z; Ren H; Chen J; Peng L; Gao F; Chen D; Wang A
    Mol Ther; 2020 Oct; 28(10):2177-2190. PubMed ID: 32621798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parp1 Deficiency Confers Defects in Chromatin Surveillance and Remodeling During Reprogramming by Nuclear Transfer.
    Osada T; Nozaki T; Masutani M
    Curr Protein Pept Sci; 2016; 17(7):693-704. PubMed ID: 27090907
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Liu J; Dou X; Chen C; Chen C; Liu C; Xu MM; Zhao S; Shen B; Gao Y; Han D; He C
    Science; 2020 Jan; 367(6477):580-586. PubMed ID: 31949099
    [No Abstract]   [Full Text] [Related]  

  • 11. Poly(ADP-Ribose) Polymerase 1 Promotes the Human Heat Shock Response by Facilitating Heat Shock Transcription Factor 1 Binding to DNA.
    Fujimoto M; Takii R; Katiyar A; Srivastava P; Nakai A
    Mol Cell Biol; 2018 Jul; 38(13):. PubMed ID: 29661921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular mechanisms of regulaion of transcription by PARP1].
    Maliuchenko NV; Kulaeva OI; Kotova E; Chupyrkina AA; Nikitin DV; Kirpichnikov MP; Studitskiĭ VM
    Mol Biol (Mosk); 2015; 49(1):99-113. PubMed ID: 25916114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3/METTL14 Transactivation and m
    Feng Y; Dong H; Sun B; Hu Y; Yang Y; Jia Y; Jia L; Zhong X; Zhao R
    Cell Mol Gastroenterol Hepatol; 2021; 12(3):839-856. PubMed ID: 33992834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. METTL3-Mediated m
    Sheng R; Wang Y; Wu Y; Wang J; Zhang S; Li Q; Zhang D; Qi X; Xiao Q; Jiang S; Yuan Q
    J Bone Miner Res; 2021 Feb; 36(2):412-423. PubMed ID: 32936965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. METTL3 modulates chromatin and transcription dynamics during cell fate transition.
    Liu XM; Mao Y; Wang S; Zhou J; Qian SB
    Cell Mol Life Sci; 2022 Oct; 79(11):559. PubMed ID: 36266520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP1-LSD1 functional interplay controls transcription of SOD2 that protects human pro-inflammatory macrophages from death under an oxidative condition.
    Tokarz P; Płoszaj T; Regdon Z; Virág L; Robaszkiewicz A
    Free Radic Biol Med; 2019 Feb; 131():218-224. PubMed ID: 30529301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-Wide Profiling of PARP1 Reveals an Interplay with Gene Regulatory Regions and DNA Methylation.
    Nalabothula N; Al-jumaily T; Eteleeb AM; Flight RM; Xiaorong S; Moseley H; Rouchka EC; Fondufe-Mittendorf YN
    PLoS One; 2015; 10(8):e0135410. PubMed ID: 26305327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revisiting PARP2 and PARP1 trapping through quantitative live-cell imaging.
    Zhang H; Lin X; Zha S
    Biochem Soc Trans; 2022 Aug; 50(4):1169-1177. PubMed ID: 35959996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PARP1-modulated chromatin remodeling is a new target for cancer treatment.
    Sinha S; Molla S; Kundu CN
    Med Oncol; 2021 Aug; 38(10):118. PubMed ID: 34432161
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Poly-ADP-Ribose Trigger Releases the Auto-Inhibition of a Chromatin Remodeling Oncogene.
    Singh HR; Nardozza AP; Möller IR; Knobloch G; Kistemaker HAV; Hassler M; Harrer N; Blessing C; Eustermann S; Kotthoff C; Huet S; Mueller-Planitz F; Filippov DV; Timinszky G; Rand KD; Ladurner AG
    Mol Cell; 2017 Dec; 68(5):860-871.e7. PubMed ID: 29220653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.